Du W - Search Results

1

Prognostic significance of CXCR4 expression in acute myeloid leukemia.

Du W, Lu C, Zhu X, Hu D, Chen X, Li J, Liu W, Zhu J, He Y, Yao J. Du W, et al. Cancer Med. 2019 Nov;8(15):6595-6603. doi: 10.1002/cam4.2535. Epub 2019 Sep 13. Cancer Med. 2019. PMID: 31518054 Free PMC article.

2

Relevance of immunophenotypes to prognostic subgroups of age, WBC, platelet count, and cytogenetics in de novo acute myeloid leukemia.

Li X, Li J, Du W, Zhang J, Liu W, Chen X, Li H, Huang S, Li X. Li X, et al. Among authors: du w. APMIS. 2011 Jan;119(1):76-84. doi: 10.1111/j.1600-0463.2010.02694.x. Epub 2010 Nov 17. APMIS. 2011. PMID: 21143529

3

Analysis of hematogones in bone marrow from acute myeloid leukaemia cases posttherapy.

Zheng J, Du W, Yao J, You Y, Li W, He Y, Li X, Liu W, Wu Y, Hu Y, Jin R, Zou P, Huang S, Hu Y, Zhang M. Zheng J, et al. Among authors: du w. Eur J Clin Invest. 2013 Nov;43(11):1140-6. doi: 10.1111/eci.12151. Epub 2013 Sep 2. Eur J Clin Invest. 2013. PMID: 23992300

4

Characterisation of clonal Philadelphia-negative cytogenetic abnormalities in a large cohort of chronic myeloid leukaemia.

Chen X, Zheng J, Liang K, He Y, Du W, Li J, Liu W, Hu Y, Huang S, Yao J. Chen X, et al. Among authors: du w. Intern Med J. 2018 Apr;48(4):439-444. doi: 10.1111/imj.13527. Intern Med J. 2018. PMID: 28636094

5

High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.

Du W, He J, Zhou W, Shu S, Li J, Liu W, Deng Y, Lu C, Lin S, Ma Y, He Y, Zheng J, Zhu J, Bai L, Li X, Yao J, Hu D, Gu S, Li H, Guo A, Huang S, Feng X, Hu D. Du W, et al. J Transl Med. 2019 Jun 6;17(1):191. doi: 10.1186/s12967-019-1926-z. J Transl Med. 2019. PMID: 31171000 Free PMC article.

6

Comprehensive profile of cytogenetics in 2308 Chinese children and adults with de novo acute myeloid leukemia.

Li X, Li X, Xie W, Hu Y, Li J, Du W, Liu W, Li H, Chen X, Zhang L, Wang J, Huang S. Li X, et al. Among authors: du w. Blood Cells Mol Dis. 2012 Aug 15;49(2):107-13. doi: 10.1016/j.bcmd.2012.05.007. Epub 2012 Jun 9. Blood Cells Mol Dis. 2012. PMID: 22683308

7

A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.

Zheng J, Wang X, Hu Y, Yang J, Liu J, He Y, Gong Q, Yao J, Li X, Du W, Huang S. Zheng J, et al. Among authors: du w. Cytometry B Clin Cytom. 2008 Jan;74(1):25-9. doi: 10.1002/cyto.b.20368. Cytometry B Clin Cytom. 2008. PMID: 18061959 Free article.

8

HERG K+ channel expression in CD34+/CD38-/CD123(high) cells and primary leukemia cells and analysis of its regulation in leukemia cells.

Li H, Liu L, Guo L, Zhang J, Du W, Li X, Liu W, Chen X, Huang S. Li H, et al. Among authors: du w. Int J Hematol. 2008 May;87(4):387-392. doi: 10.1007/s12185-008-0056-9. Int J Hematol. 2008. PMID: 18415658

9

Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells.

Li H, Guo L, Jie S, Liu W, Zhu J, Du W, Fan L, Wang X, Fu B, Huang S. Li H, et al. Among authors: du w. Biomed Pharmacother. 2008 Nov;62(9):573-8. doi: 10.1016/j.biopha.2008.08.003. Epub 2008 Sep 4. Biomed Pharmacother. 2008. PMID: 18805669

10

The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration.

Li H, Du YM, Guo L, Jie S, Zhang S, Du W, Chen X, Liu W, Fan L, Zhu J, Zou A, Huang S. Li H, et al. Among authors: du ym, du w. Exp Cell Res. 2009 Aug 1;315(13):2256-64. doi: 10.1016/j.yexcr.2009.04.017. Epub 2009 May 3. Exp Cell Res. 2009. PMID: 19409379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,247 results

Search Page

Filters